| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Fecal Microbiota Transplantation | 15 | 2021 | 372 | 7.59 | Why? |
| Clostridium Infections | 14 | 2020 | 595 | 5.07 | Why? |
| Gastrointestinal Microbiome | 11 | 2021 | 1961 | 2.32 | Why? |
| Donor Selection | 6 | 2021 | 804 | 1.94 | Why? |
| Noninvasive Ventilation | 6 | 2021 | 2329 | 1.28 | Why? |
| Diaphragm | 2 | 2021 | 232 | 0.87 | Why? |
| Enterocolitis, Pseudomembranous | 2 | 2018 | 93 | 0.79 | Why? |
| Bacteriocins | 1 | 2019 | 13 | 0.78 | Why? |
| Gastroenterology | 2 | 2020 | 1352 | 0.76 | Why? |
| Non-alcoholic Fatty Liver Disease | 3 | 2018 | 907 | 0.76 | Why? |
| Hospital Design and Construction | 1 | 2020 | 287 | 0.66 | Why? |
| Wakefulness | 1 | 2021 | 598 | 0.62 | Why? |
| Ventilator Weaning | 1 | 2021 | 536 | 0.62 | Why? |
| Bacteriophages | 1 | 2019 | 268 | 0.61 | Why? |
| Patient Selection | 3 | 2020 | 4560 | 0.60 | Why? |
| Colonoscopy | 3 | 2018 | 738 | 0.58 | Why? |
| Vancomycin | 1 | 2018 | 328 | 0.58 | Why? |
| Intestinal Diseases | 1 | 2018 | 231 | 0.56 | Why? |
| Inflammatory Bowel Diseases | 6 | 2018 | 3209 | 0.56 | Why? |
| Feces | 9 | 2021 | 4235 | 0.53 | Why? |
| Gastrointestinal Neoplasms | 1 | 2019 | 392 | 0.52 | Why? |
| Biological Specimen Banks | 1 | 2021 | 1142 | 0.50 | Why? |
| Helicobacter Infections | 5 | 2018 | 216 | 0.48 | Why? |
| Surge Capacity | 1 | 2020 | 894 | 0.47 | Why? |
| Helicobacter pylori | 5 | 2018 | 262 | 0.47 | Why? |
| Metabolic Diseases | 1 | 2017 | 505 | 0.46 | Why? |
| Gastrointestinal Diseases | 4 | 2020 | 2580 | 0.44 | Why? |
| Patient Positioning | 1 | 2021 | 1505 | 0.42 | Why? |
| Respiration, Artificial | 9 | 2021 | 22116 | 0.41 | Why? |
| Celiac Disease | 4 | 2021 | 471 | 0.40 | Why? |
| Anti-Bacterial Agents | 5 | 2019 | 10083 | 0.40 | Why? |
| Intestinal Mucosa | 2 | 2019 | 1046 | 0.39 | Why? |
| Prone Position | 1 | 2021 | 1861 | 0.39 | Why? |
| Fluid Therapy | 3 | 2019 | 628 | 0.39 | Why? |
| Irritable Bowel Syndrome | 4 | 2017 | 175 | 0.38 | Why? |
| Drug Resistance, Bacterial | 1 | 2018 | 1414 | 0.36 | Why? |
| Critical Pathways | 1 | 2019 | 1587 | 0.36 | Why? |
| Cross Infection | 3 | 2019 | 8675 | 0.36 | Why? |
| Colitis, Ulcerative | 1 | 2018 | 1037 | 0.35 | Why? |
| Ventilators, Mechanical | 1 | 2020 | 2193 | 0.34 | Why? |
| Microbiota | 1 | 2017 | 1240 | 0.33 | Why? |
| Cardiac Output | 2 | 2018 | 183 | 0.33 | Why? |
| Specimen Handling | 3 | 2020 | 6190 | 0.31 | Why? |
| Melanoma | 1 | 2017 | 1229 | 0.30 | Why? |
| Recurrence | 5 | 2020 | 3675 | 0.29 | Why? |
| Pulmonary Disease, Chronic Obstructive | 3 | 2019 | 3832 | 0.28 | Why? |
| Consensus | 1 | 2019 | 6345 | 0.28 | Why? |
| Humans | 59 | 2021 | 930598 | 0.24 | Why? |
| Inflammation | 4 | 2019 | 13255 | 0.23 | Why? |
| Diet, Gluten-Free | 2 | 2021 | 185 | 0.22 | Why? |
| Critical Care | 3 | 2020 | 14081 | 0.20 | Why? |
| Gastritis | 2 | 1997 | 66 | 0.20 | Why? |
| Malabsorption Syndromes | 1 | 2019 | 19 | 0.20 | Why? |
| Bacillus clausii | 1 | 2018 | 4 | 0.19 | Why? |
| Vena Cava Filters | 1 | 2020 | 89 | 0.19 | Why? |
| Echocardiography, Doppler, Pulsed | 1 | 2018 | 40 | 0.19 | Why? |
| Tinidazole | 1 | 1998 | 9 | 0.19 | Why? |
| Intubation | 1 | 2021 | 437 | 0.19 | Why? |
| Triticum | 1 | 2019 | 54 | 0.19 | Why? |
| Vasculitis, Central Nervous System | 1 | 2020 | 97 | 0.19 | Why? |
| Anti-Ulcer Agents | 1 | 1998 | 24 | 0.19 | Why? |
| Organizational Case Studies | 1 | 2020 | 293 | 0.19 | Why? |
| Hypovolemia | 1 | 2019 | 65 | 0.19 | Why? |
| Lymphoid Tissue | 2 | 1997 | 162 | 0.19 | Why? |
| Intestines | 2 | 2017 | 817 | 0.19 | Why? |
| Ranitidine | 1 | 1998 | 27 | 0.18 | Why? |
| Italy | 8 | 2021 | 38444 | 0.18 | Why? |
| Bismuth | 1 | 1998 | 56 | 0.18 | Why? |
| Prospective Studies | 9 | 2021 | 43301 | 0.18 | Why? |
| Combined Modality Therapy | 2 | 2018 | 3395 | 0.18 | Why? |
| Monitoring, Intraoperative | 1 | 2019 | 140 | 0.18 | Why? |
| Diverticular Diseases | 1 | 2017 | 26 | 0.18 | Why? |
| Diarrhea | 3 | 2019 | 2743 | 0.18 | Why? |
| Head Protective Devices | 1 | 2019 | 163 | 0.18 | Why? |
| Hospital Planning | 1 | 2020 | 238 | 0.17 | Why? |
| Amoxicillin | 1 | 1998 | 98 | 0.17 | Why? |
| Interactive Ventilatory Support | 1 | 2017 | 25 | 0.17 | Why? |
| Bacterial Physiological Phenomena | 1 | 2017 | 31 | 0.17 | Why? |
| Clarithromycin | 1 | 1998 | 112 | 0.17 | Why? |
| Antibodies, Monoclonal | 1 | 2017 | 8041 | 0.17 | Why? |
| Clinical Studies as Topic | 1 | 2018 | 118 | 0.17 | Why? |
| Health | 1 | 2017 | 130 | 0.16 | Why? |
| Respiratory Physiological Phenomena | 1 | 2017 | 157 | 0.15 | Why? |
| Duodenal Diseases | 1 | 1995 | 30 | 0.15 | Why? |
| Risk Adjustment | 1 | 2020 | 730 | 0.15 | Why? |
| Leukocyte L1 Antigen Complex | 1 | 2017 | 238 | 0.15 | Why? |
| Laparotomy | 1 | 2017 | 241 | 0.15 | Why? |
| Cross-Over Studies | 4 | 2019 | 867 | 0.14 | Why? |
| Living Donors | 1 | 2020 | 652 | 0.14 | Why? |
| Male | 27 | 2021 | 367725 | 0.13 | Why? |
| Gastrointestinal Tract | 2 | 2020 | 1113 | 0.13 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.13 | Why? |
| Length of Stay | 3 | 2021 | 11042 | 0.13 | Why? |
| Observational Studies as Topic | 1 | 2021 | 1887 | 0.13 | Why? |
| Liver | 2 | 2018 | 4007 | 0.13 | Why? |
| Pneumonia, Ventilator-Associated | 1 | 2021 | 861 | 0.13 | Why? |
| Female | 26 | 2021 | 380317 | 0.13 | Why? |
| Cannula | 1 | 2019 | 750 | 0.13 | Why? |
| Infliximab | 1 | 2017 | 502 | 0.13 | Why? |
| Gastrointestinal Agents | 1 | 2017 | 393 | 0.13 | Why? |
| Mesalamine | 1 | 2013 | 89 | 0.12 | Why? |
| Metabolic Syndrome | 2 | 2018 | 810 | 0.12 | Why? |
| Respiratory Mechanics | 1 | 2017 | 585 | 0.12 | Why? |
| Program Evaluation | 1 | 2021 | 1929 | 0.12 | Why? |
| Positive-Pressure Respiration | 1 | 2021 | 1160 | 0.12 | Why? |
| Cohort Studies | 5 | 2021 | 36005 | 0.12 | Why? |
| Calcium | 1 | 2018 | 708 | 0.12 | Why? |
| Proton Pump Inhibitors | 1 | 2017 | 377 | 0.12 | Why? |
| Continuous Positive Airway Pressure | 1 | 2021 | 1187 | 0.12 | Why? |
| Intensive Care Units | 5 | 2021 | 29594 | 0.12 | Why? |
| Dysbiosis | 1 | 2018 | 685 | 0.11 | Why? |
| Hypnotics and Sedatives | 1 | 2017 | 624 | 0.11 | Why? |
| Kaplan-Meier Estimate | 1 | 2021 | 4260 | 0.11 | Why? |
| Pilot Projects | 2 | 2021 | 5182 | 0.11 | Why? |
| Aged | 16 | 2021 | 215776 | 0.11 | Why? |
| Piperidines | 1 | 2017 | 795 | 0.11 | Why? |
| Middle Aged | 19 | 2021 | 270681 | 0.11 | Why? |
| Workflow | 1 | 2020 | 2373 | 0.11 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.11 | Why? |
| Metformin | 1 | 2018 | 640 | 0.11 | Why? |
| Aged, 80 and over | 7 | 2020 | 88759 | 0.10 | Why? |
| Treatment Failure | 1 | 2017 | 2106 | 0.10 | Why? |
| Hospitals, Teaching | 1 | 2019 | 1609 | 0.10 | Why? |
| Probiotics | 1 | 2018 | 694 | 0.10 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.10 | Why? |
| Europe | 2 | 2018 | 12702 | 0.10 | Why? |
| Bacterial Infections | 2 | 2019 | 2229 | 0.10 | Why? |
| Blood Pressure | 2 | 2019 | 2198 | 0.10 | Why? |
| Hospital Units | 1 | 2017 | 1017 | 0.10 | Why? |
| Monitoring, Physiologic | 1 | 2021 | 1956 | 0.10 | Why? |
| Airway Management | 1 | 2019 | 1298 | 0.09 | Why? |
| Crohn Disease | 1 | 2018 | 959 | 0.09 | Why? |
| Health Facilities | 1 | 2017 | 1230 | 0.09 | Why? |
| Heart Rate | 1 | 2017 | 1527 | 0.09 | Why? |
| Ultrasonography | 2 | 2021 | 4409 | 0.09 | Why? |
| Tracheostomy | 1 | 2021 | 1963 | 0.09 | Why? |
| Adult | 15 | 2021 | 244371 | 0.09 | Why? |
| Immunodeficiency Virus, Feline | 2 | 1999 | 38 | 0.09 | Why? |
| Neurosurgical Procedures | 1 | 2019 | 1738 | 0.08 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.08 | Why? |
| Infection Control | 3 | 2021 | 23131 | 0.08 | Why? |
| Treatment Outcome | 6 | 2019 | 51732 | 0.08 | Why? |
| Hospital Mortality | 2 | 2021 | 22087 | 0.08 | Why? |
| Evidence-Based Medicine | 2 | 2017 | 3228 | 0.08 | Why? |
| Time Factors | 5 | 2021 | 31397 | 0.08 | Why? |
| Tidal Volume | 2 | 2019 | 565 | 0.08 | Why? |
| Quality Improvement | 1 | 2019 | 2435 | 0.08 | Why? |
| Masks | 2 | 2019 | 8528 | 0.07 | Why? |
| Enhancer Elements, Genetic | 1 | 2004 | 48 | 0.07 | Why? |
| Animals | 5 | 2019 | 78931 | 0.07 | Why? |
| Health Services Needs and Demand | 1 | 2020 | 3419 | 0.07 | Why? |
| Oxygen Inhalation Therapy | 1 | 2019 | 3629 | 0.07 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2021 | 10649 | 0.07 | Why? |
| Hydrogen | 1 | 2005 | 195 | 0.07 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.07 | Why? |
| Immunoglobulin Heavy Chains | 1 | 2004 | 222 | 0.06 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.06 | Why? |
| Skin Neoplasms | 1 | 2017 | 1679 | 0.06 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 1454 | 0.06 | Why? |
| Patient Discharge | 1 | 2019 | 5696 | 0.06 | Why? |
| Glucose | 1 | 2005 | 573 | 0.06 | Why? |
| Elective Surgical Procedures | 1 | 2019 | 5338 | 0.05 | Why? |
| Tertiary Care Centers | 1 | 2019 | 8248 | 0.05 | Why? |
| Antineoplastic Agents | 1 | 2017 | 3550 | 0.05 | Why? |
| Pulmonary Embolism | 1 | 2020 | 4775 | 0.05 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.05 | Why? |
| Practice Patterns, Physicians' | 1 | 2018 | 4927 | 0.05 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.05 | Why? |
| Lymphoma, B-Cell, Marginal Zone | 2 | 1997 | 44 | 0.05 | Why? |
| Gene Frequency | 1 | 2004 | 1210 | 0.05 | Why? |
| Immunity, Innate | 1 | 2018 | 6570 | 0.05 | Why? |
| Tomography, X-Ray Computed | 3 | 2021 | 25144 | 0.05 | Why? |
| Lentivirus Infections | 1 | 1999 | 47 | 0.05 | Why? |
| Air Pressure | 1 | 2019 | 119 | 0.05 | Why? |
| Stroke Volume | 2 | 2019 | 2153 | 0.05 | Why? |
| Enterotoxins | 1 | 2019 | 115 | 0.05 | Why? |
| Patient Comfort | 1 | 2019 | 74 | 0.04 | Why? |
| Bacterial Toxins | 1 | 2019 | 185 | 0.04 | Why? |
| Repressor Proteins | 1 | 2019 | 232 | 0.04 | Why? |
| Gastroscopy | 1 | 1998 | 112 | 0.04 | Why? |
| Double-Blind Method | 2 | 2019 | 5988 | 0.04 | Why? |
| Genetic Techniques | 1 | 2017 | 79 | 0.04 | Why? |
| Biomarkers | 2 | 2017 | 23361 | 0.04 | Why? |
| ROC Curve | 2 | 2019 | 6024 | 0.04 | Why? |
| Incidence | 1 | 2019 | 25622 | 0.04 | Why? |
| Gastric Mucosa | 1 | 1997 | 141 | 0.04 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.04 | Why? |
| Age of Onset | 1 | 2018 | 557 | 0.04 | Why? |
| Pulmonary Gas Exchange | 1 | 2019 | 414 | 0.04 | Why? |
| Adrenal Cortex Hormones | 1 | 2013 | 6537 | 0.04 | Why? |
| Principal Component Analysis | 1 | 2017 | 689 | 0.04 | Why? |
| Respiratory Rate | 1 | 2019 | 691 | 0.04 | Why? |
| Genome | 1 | 2017 | 341 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2019 | 15421 | 0.03 | Why? |
| Emergency Service, Hospital | 1 | 2019 | 14232 | 0.03 | Why? |
| Blood Gas Analysis | 1 | 2017 | 893 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2017 | 1224 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| Species Specificity | 1 | 2017 | 1356 | 0.03 | Why? |
| Severity of Illness Index | 2 | 2018 | 48226 | 0.03 | Why? |
| Lung | 1 | 2021 | 31049 | 0.03 | Why? |
| Area Under Curve | 1 | 2019 | 2564 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2019 | 53120 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 1998 | 2324 | 0.03 | Why? |
| Antibodies | 1 | 2017 | 846 | 0.03 | Why? |
| Bone Marrow | 1 | 1994 | 492 | 0.03 | Why? |
| Hemodynamics | 1 | 2019 | 1562 | 0.03 | Why? |
| Coronary Vessels | 1 | 2018 | 914 | 0.03 | Why? |
| Stomach Neoplasms | 1 | 1996 | 477 | 0.03 | Why? |
| Bacterial Proteins | 1 | 2019 | 1318 | 0.03 | Why? |
| RNA | 1 | 2017 | 1278 | 0.02 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.02 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.02 | Why? |
| Fibrinolytic Agents | 1 | 2020 | 1702 | 0.02 | Why? |
| Operating Rooms | 1 | 2019 | 1841 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.02 | Why? |
| Equipment Design | 1 | 2019 | 3095 | 0.02 | Why? |
| Hospitalization | 1 | 2019 | 54280 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2017 | 2483 | 0.02 | Why? |
| Whole Genome Sequencing | 1 | 2017 | 3239 | 0.02 | Why? |
| Locus Control Region | 1 | 2004 | 1 | 0.02 | Why? |
| Chromosomes, Human, Pair 14 | 1 | 2004 | 4 | 0.02 | Why? |
| Genes, Immunoglobulin | 1 | 2004 | 50 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| Life Style | 1 | 2018 | 2708 | 0.02 | Why? |
| Hypoglycemic Agents | 1 | 2018 | 2165 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 1998 | 7268 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2019 | 9537 | 0.02 | Why? |
| DNA, Viral | 1 | 1994 | 2521 | 0.02 | Why? |
| Magnetic Resonance Imaging | 1 | 2020 | 6551 | 0.02 | Why? |
| Genetic Markers | 1 | 2004 | 318 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2019 | 11304 | 0.01 | Why? |
| Breath Tests | 1 | 2005 | 338 | 0.01 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.01 | Why? |
| Cats | 2 | 1999 | 1890 | 0.01 | Why? |
| Disease Progression | 1 | 2019 | 13580 | 0.01 | Why? |
| Polymerase Chain Reaction | 1 | 1994 | 6740 | 0.01 | Why? |
| Immunosuppressive Agents | 1 | 2017 | 6331 | 0.01 | Why? |
| Proviruses | 1 | 1999 | 82 | 0.01 | Why? |
| Phylogeny | 1 | 2017 | 13341 | 0.01 | Why? |
| Virus Replication | 1 | 1999 | 14331 | 0.01 | Why? |
| Polymorphism, Genetic | 1 | 2004 | 1074 | 0.01 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2018 | 8207 | 0.01 | Why? |
| Infant | 1 | 2018 | 30274 | 0.01 | Why? |
| Feline Acquired Immunodeficiency Syndrome | 1 | 1994 | 21 | 0.01 | Why? |
| Densitometry | 1 | 1994 | 40 | 0.01 | Why? |
| Critical Illness | 1 | 2018 | 17281 | 0.01 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.01 | Why? |
| CD4 Lymphocyte Count | 1 | 1999 | 1517 | 0.01 | Why? |
| Cardiovascular Diseases | 1 | 2018 | 11497 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Genotype | 1 | 2004 | 4697 | 0.01 | Why? |
| Risk Factors | 2 | 2018 | 71621 | 0.01 | Why? |
| Kinetics | 1 | 1999 | 3238 | 0.01 | Why? |
| China | 1 | 2017 | 50654 | 0.01 | Why? |
| Genetic Predisposition to Disease | 1 | 2004 | 4027 | 0.01 | Why? |
| Leukocytes, Mononuclear | 1 | 1999 | 2115 | 0.01 | Why? |
| Child | 1 | 2018 | 70012 | 0.01 | Why? |
| Molecular Sequence Data | 1 | 1994 | 3198 | 0.01 | Why? |
| Case-Control Studies | 1 | 2005 | 17671 | 0.00 | Why? |
| Base Sequence | 1 | 1994 | 3581 | 0.00 | Why? |
| Adolescent | 1 | 1995 | 86841 | 0.00 | Why? |
| Follow-Up Studies | 1 | 1997 | 17020 | 0.00 | Why? |
| Viral Load | 1 | 1999 | 15850 | 0.00 | Why? |
| Antibodies, Viral | 1 | 1999 | 51949 | 0.00 | Why? |